Global Nuclear Medicine/Radiopharmaceuticals Market Research Report 2020

Global Nuclear Medicine/Radiopharmaceuticals Market Research Report 2020

Table of Contents
1 Nuclear Medicine/Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceuticals
1.2 Nuclear Medicine/Radiopharmaceuticals Segment by Type
1.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Diagnostic
1.2.3 Therapeutic
1.3 Nuclear Medicine/Radiopharmaceuticals Segment by Application
1.3.1 Nuclear Medicine/Radiopharmaceuticals Sales Comparison by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.4 Global Nuclear Medicine/Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue 2015-2026
1.4.2 Global Nuclear Medicine/Radiopharmaceuticals Sales 2015-2026
1.4.3 Nuclear Medicine/Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
2 Global Nuclear Medicine/Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
2.3 Global Nuclear Medicine/Radiopharmaceuticals Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nuclear Medicine/Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Nuclear Medicine/Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Nuclear Medicine/Radiopharmaceuticals Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Nuclear Medicine/Radiopharmaceuticals Players (Opinion Leaders)
3 Nuclear Medicine/Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Nuclear Medicine/Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Nuclear Medicine/Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Country
3.3.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Country
3.3.2 North America Nuclear Medicine/Radiopharmaceuticals Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country
3.4.2 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region
3.5.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country
3.6.2 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country
3.7.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Nuclear Medicine/Radiopharmaceuticals Historic Market Analysis by Type
4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
4.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
4.3 Global Nuclear Medicine/Radiopharmaceuticals Price Market Share by Type (2015-2020)
4.4 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Nuclear Medicine/Radiopharmaceuticals Historic Market Analysis by Application
5.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
5.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
5.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Application (2015-2020)
6 Company Profiles and Key Figures in Nuclear Medicine/Radiopharmaceuticals Business
6.1 China Isotope & Radiation
6.1.1 Corporation Information
6.1.2 China Isotope & Radiation Description, Business Overview and Total Revenue
6.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.1.4 China Isotope & Radiation Products Offered
6.1.5 China Isotope & Radiation Recent Development
6.2 Dongcheng
6.2.1 Dongcheng Nuclear Medicine/Radiopharmaceuticals Production Sites and Area Served
6.2.2 Dongcheng Description, Business Overview and Total Revenue
6.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Dongcheng Products Offered
6.2.5 Dongcheng Recent Development
6.3 Jaco
6.3.1 Jaco Nuclear Medicine/Radiopharmaceuticals Production Sites and Area Served
6.3.2 Jaco Description, Business Overview and Total Revenue
6.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Jaco Products Offered
6.3.5 Jaco Recent Development
6.4 Ciaeriar
6.4.1 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Production Sites and Area Served
6.4.2 Ciaeriar Description, Business Overview and Total Revenue
6.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ciaeriar Products Offered
6.4.5 Ciaeriar Recent Development
6.5 Advanced Molecular-imaging Solution
6.5.1 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Production Sites and Area Served
6.5.2 Advanced Molecular-imaging Solution Description, Business Overview and Total Revenue
6.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Advanced Molecular-imaging Solution Products Offered
6.5.5 Advanced Molecular-imaging Solution Recent Development
6.6 Shanghai Atom Kexing
6.6.1 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Production Sites and Area Served
6.6.2 Shanghai Atom Kexing Description, Business Overview and Total Revenue
6.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Shanghai Atom Kexing Products Offered
6.6.5 Shanghai Atom Kexing Recent Development
7 Nuclear Medicine/Radiopharmaceuticals Manufacturing Cost Analysis
7.1 Nuclear Medicine/Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals
7.4 Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nuclear Medicine/Radiopharmaceuticals Distributors List
8.3 Nuclear Medicine/Radiopharmaceuticals Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Nuclear Medicine/Radiopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nuclear Medicine/Radiopharmaceuticals by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceuticals by Type (2021-2026)
10.2 Nuclear Medicine/Radiopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nuclear Medicine/Radiopharmaceuticals by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceuticals by Application (2021-2026)
10.3 Nuclear Medicine/Radiopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nuclear Medicine/Radiopharmaceuticals by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceuticals by Region (2021-2026)
10.4 North America Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2021-2026)
10.5 Europe Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2021-2026)
10.6 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2021-2026)
10.7 Latin America Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2021-2026)
10.8 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Nuclear Medicine/Radiopharmaceuticals Manufacturers Covered in This Study
Table 5. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 7. Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Nuclear Medicine/Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Nuclear Medicine/Radiopharmaceuticals Sales Sites and Area Served
Table 11. Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Types
Table 12. Global Nuclear Medicine/Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nuclear Medicine/Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Nuclear Medicine/Radiopharmaceuticals Players
Table 16. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Region (2015-2020)
Table 17. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 18. Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million US$) by Region (2015-2020)
Table 19. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 20. North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 21. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 22. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 24. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 25. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 26. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 32. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 33. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 34. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 40. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 41. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 42. Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million US$) by Type (2015-2020)
Table 43. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 44. Global Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) by Type (2015-2020)
Table 45. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 46. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 47. Global Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate by Application (2015-2020)
Table 48. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Corporation Information
Table 49. China Isotope & Radiation Description and Business Overview
Table 50. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. China Isotope & Radiation Main Product
Table 52. China Isotope & Radiation Recent Development
Table 53. Dongcheng Nuclear Medicine/Radiopharmaceuticals Corporation Information
Table 54. Dongcheng Corporation Information
Table 55. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Dongcheng Main Product
Table 57. Dongcheng Recent Development
Table 58. Jaco Nuclear Medicine/Radiopharmaceuticals Corporation Information
Table 59. Jaco Corporation Information
Table 60. Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Jaco Main Product
Table 62. Jaco Recent Development
Table 63. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Corporation Information
Table 64. Ciaeriar Corporation Information
Table 65. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Ciaeriar Main Product
Table 67. Ciaeriar Recent Development
Table 68. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Corporation Information
Table 69. Advanced Molecular-imaging Solution Corporation Information
Table 70. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Advanced Molecular-imaging Solution Main Product
Table 72. Advanced Molecular-imaging Solution Recent Development
Table 73. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Corporation Information
Table 74. Shanghai Atom Kexing Corporation Information
Table 75. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Shanghai Atom Kexing Main Product
Table 77. Shanghai Atom Kexing Recent Development
Table 78. Sales Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Nuclear Medicine/Radiopharmaceuticals Distributors List
Table 81. Nuclear Medicine/Radiopharmaceuticals Customers List
Table 82. Market Key Trends
Table 83. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 84. Key Challenges
Table 85. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Type (2021-2026)
Table 86. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2026)
Table 87. Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million US$) Forecast by Type (2021-2026)
Table 88. Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 89. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Application (2021-2026)
Table 90. Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million US$) Forecast by Application (2021-2026)
Table 91. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Region (2021-2026)
Table 92. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2026)
Table 93. Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 94. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Region (2021-2026)
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Nuclear Medicine/Radiopharmaceuticals
Figure 2. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type: 2020 VS 2026
Figure 3. Diagnostic Product Picture
Figure 4. Therapeutic Product Picture
Figure 5. Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application: 2020 VS 2026
Figure 6. Oncology
Figure 7. Thyroid
Figure 8. Cardiology
Figure 9. Global Nuclear Medicine/Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 10. Global Nuclear Medicine/Radiopharmaceuticals Sales Capacity (K Units) (2015-2026)
Figure 11. Global Nuclear Medicine/Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers in 2020
Figure 13. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine/Radiopharmaceuticals Revenue in 2019
Figure 15. Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Figure 17. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 18. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 19. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 20. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 21. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 22. U.S. Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 27. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 28. Germany Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 39. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 40. China Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 63. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 64. Mexico Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 72. Turkey Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Type (2015-2020)
Figure 79. Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Type in 2019
Figure 80. Revenue Share of Nuclear Medicine/Radiopharmaceuticals by Type (2015-2020)
Figure 81. Revenue Market Share of Nuclear Medicine/Radiopharmaceuticals by Type in 2019
Figure 82. Global Nuclear Medicine/Radiopharmaceuticals Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 84. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Nuclear Medicine/Radiopharmaceuticals by Application (2015-2020)
Figure 86. Global Revenue Share of Nuclear Medicine/Radiopharmaceuticals by Application in 2020
Figure 87. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Jaco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Ciaeriar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Advanced Molecular-imaging Solution Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Shanghai Atom Kexing Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Price Trend of Key Raw Materials
Figure 94. Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceuticals
Figure 95. Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals
Figure 96. Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Porter's Five Forces Analysis
Figure 100. North America Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 101. North America Nuclear Medicine/Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 102. Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 103. Europe Nuclear Medicine/Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Latin America Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Nuclear Medicine market size was valued at US$ 6054.6 million in 2023. With growing demand in downstream market, the Nuclear Medicine is forecast to a readjusted size of US$ 10160 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Nuclear Medicine market. Nuclear Medicine are expected to show stable growth in the future market. However, product different......

Global Nuclear Imaging Equipment Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 138

Nuclear medicine uses a special gamma camera and single-photon emission-computed tomography (SPECT) imaging techniques. The gamma camera records the energy emissions from the radiotracer in your body and converts it into an image. The gamma camera itself does not emit any radiation. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each seg......

Global Nuclear Imaging Equipment Professional Survey Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 107

Nuclear medicine uses a special gamma camera and single-photon emission-computed tomography (SPECT) imaging techniques. The gamma camera records the energy emissions from the radiotracer in your body and converts it into an image. The gamma camera itself does not emit any radiation. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each seg......

Global Gamma Camera Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 104

Market Overview of Global Gamma Camera market: According to our latest research, the global Gamma Camera market looks promising in the next 5 years. As of 2022, the global Gamma Camera market was estimated at USD 622.4 million, and it's anticipated to reach USD 742.27 million in 2028, with a CAGR of 2.98% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Gamma Camera market, with ......

Global Nuclear Imaging Equipment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Nuclear Imaging Equipment market: According to our latest research, the global Nuclear Imaging Equipment market looks promising in the next 5 years. As of 2022, the global Nuclear Imaging Equipment market was estimated at USD 3813.05 million, and it's anticipated to reach USD 5077.36 million in 2028, with a CAGR of 4.89% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Nuclear Medicine Equipment Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 93

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nuclear Medicine Equipment market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Philips - Siemens - Digirad - Mediso Medical Imaging Systems - Toshiba - Bozlu - Neusoft - Compañía Mexicana - SurgicE......

Global Nuclear Imaging Systems Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 97

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nuclear Imaging Systems market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - GE Healthcare - Siemens Healthcare - Philips Healthcare - Canon Medical Systems - Hitachi Medical - Digirad Corporation - DDD-Diagnosti......

Global Nuclear Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 105

Market Overview of Global Nuclear Medicine market: According to our latest research, the global Nuclear Medicine market looks promising in the next 5 years. As of 2022, the global Nuclear Medicine market was estimated at USD 4471.65 million, and it's anticipated to reach USD 7074.48 million in 2028, with a CAGR of 7.95% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nuclear Med......

Global Nuclear Imaging Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Nov-2023        Price: US 3380 Onwards        Pages: 104

Market Overview of Global Nuclear Imaging market: According to our latest research, the global Nuclear Imaging market looks promising in the next 5 years. As of 2022, the global Nuclear Imaging market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nuclear Imaging market, wi......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs